Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk

被引:212
作者
NelsonPiercy, C
Letsky, EA
deSwiet, M
机构
[1] Institute of Obstetrics/Gynecology, Queen Charlotte's Hospital, London W6 OXG, Goldhawk Road
关键词
low-molecular-weight heparin; pregnancy; bone densitometry; thromboprophylaxis;
D O I
10.1016/S0002-9378(97)70403-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to investigate the use of low-molecular-weight hepa STUDY DESIGN: A prospective consecutive cohort of 61 pregnant women at high risk of: thromboembolism receiving antenatal thromboprophylaxis with enoxaparin (usually 40 mg, subcutaneously daily) in a total of 69 pregnancies was identified from the obstetric medicine clinic at Queen Charlotte's Hospital. Bone density measurements of the hip and lumbar spine were taken in 26 women after 28 pregnancies within 16 months post partum. Nonparametric statistics were used for comparisons. RESULTS: There were no episodes of antenatal thromboembolism. One woman (1.6%] (receiving 20 mg of enoxaparin) had a pulmonary embolus post partum. Heparin levels (anti-Xa assay) were greater with the 40 mg dose (median 0.09 U/ml) than with the 20 mg dose (median 0.03 U/ml) (p = 0.0006) but were not affected by gestational age (r = -0.1, p = 0.14). Enoxaparin had no effect on platelet count or on in vitro coagulation tests. Nine (32%) women had bone density in the spine or hip >1 SD below the mean for age- and sex-matched controls. CONCLUSION: This, the largest study to date of low-molecular-weight heparin use in pregnancy, confirms previous reports that it is a safe and effective alternative to unfractionated heparin far obstetric thromboprophylaxis in high-risk women. Effects on bone demineralization require further investigation.
引用
收藏
页码:1062 / 1068
页数:7
相关论文
共 25 条
[1]   HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS [J].
ASTER, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1374-1376
[2]   A PROSPECTIVE-STUDY OF HEPARIN-INDUCED OSTEOPOROSIS IN PREGNANCY USING BONE DENSITOMETRY [J].
BARBOUR, LA ;
KICK, SD ;
STEINER, JF ;
LOVERDE, ME ;
HEDDLESTON, LN ;
LEAR, JL ;
BARON, AE ;
BARTON, PL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (03) :862-869
[3]   LOW-MOLECULAR-WEIGHT HEPARIN FOR THROMBOPROPHYLAXIS AND EPIDURAL SPINAL-ANESTHESIA - IS THERE A RISK [J].
BERGQVIST, D ;
LINDBLAD, B ;
MATZSCH, T .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1992, 36 (07) :605-609
[4]  
BERTOLI D, 1986, DRUG RES, V36, P1260
[5]   OSTEOPENIA IN PREGNANCY DURING LONG-TERM HEPARIN TREATMENT - A RADIOLOGICAL STUDY POST PARTUM [J].
DAHLMAN, T ;
LINDVALL, N ;
HELLGREN, M .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (03) :221-228
[6]   OSTEOPOROTIC FRACTURES AND THE RECURRENCE OF THROMBOEMBOLISM DURING PREGNANCY AND THE PUERPERIUM IN 184 WOMEN UNDERGOING THROMBOPROPHYLAXIS WITH HEPARIN [J].
DAHLMAN, TC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (04) :1265-1270
[7]  
DAHLMAN TC, 1994, AM J OBSTET GYNECOL, V170, P1315
[8]  
*DEP HLTH WELSH OF, 1996, CONF ENQ MAT DEATHS
[9]   Low-molecular-weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies [J].
Dulitzki, M ;
Pauzner, R ;
Langevitz, P ;
Pras, M ;
Many, A ;
Schiff, E .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (03) :380-383
[10]   USE OF LOW-MOLECULAR-WEIGHT HEPARIN FOR PROPHYLAXIS AND TREATMENT OF THROMBOEMBOLISM IN PREGNANCY [J].
GILLIS, S ;
SHUSHAN, A ;
ELDOR, A .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1992, 39 (04) :297-301